Optimal medical therapy: Clinical Trials

35 trials of Optimal medical therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 8 recruiting, 6 terminated, 6 unknown. 22 Not applicable, 5 Phase 4, 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable22Completed 6, Recruiting 6, Terminated 3, Unknown 3, Active not recruiting 2, Not yet recruiting 1, Withdrawn 1
Phase 45Completed 2, Recruiting 1, Terminated 1, Unknown 1
Phase 33Terminated 2, Completed 1
Phase 22Active not recruiting 1, Suspended 1

Follow Optimal medical therapy: new trials by email Literature Review of Optimal medical therapy trials Research Report on Optimal medical therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
TricValve System, Optimal medical therapy - Tricuspid Valve Disease, Heart Valve Diseases
Not applicableNot yet recruitingP+F Products + Features USA Inc.7802026-10-012026-10-09
Edge-to-edge Mitral Valve Repair in ATTR-CM
TEER, Optimal Medical Therapy - Mitral Regurgitation, ATTR-Cardiomyopathy
Not applicableRecruitingMedical University of Vienna1062024-01-012026-10-16
Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease
Individual rehabilitation exercise training, optimal medical therapy :aspirin, clopidogrel, statins. - Coronary Heart Disease
Not applicableRecruitingThe First Affiliated Hospital with Nanjing Medical University2002023-10-172024-12-31
Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion
PCI, OMT - Coronary Atheroscleroses
RecruitingThe First Affiliated Hospital with Nanjing Medical University2582023-09-172024-12-27
A Randomized Controlled Trial of InterVapor® in France - The TARGET Trial
Treatment plus Optimal Medical Therapy, Optimal Medical Therapy - Emphysema
Not applicableTerminatedUptake Medical Technology, Inc.32023-07-212025-02-27
A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction
Vericiguat, Optimal medical therapy - Breast Cancer, Cardiac Dysfunction
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center212023-07-172026-08-03
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
Transcatheter Aortic Valve Implantation, Medical therapy - Aortic Valve Disease
Not applicableRecruitingNanjing First Hospital, Nanjing Medical University2102021-05-212026-04-08
TRISCEND II Pivotal Trial
Edwards EVOQUE System, Optimal Medical Therapy - Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency
Not applicableActive not recruitingEdwards Lifesciences8642021-04-092026-02-27
COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina
Coronary sinus reducer, Optimal medical therapy - Coronary Microvascular Disease, Refractory Angina
Not applicableRecruitingJohannes Gutenberg University Mainz1442021-04-012023-09-28
EndovaScular Versus mediCaL mAnagement of Uncomplicated Type B Intramural heMatoma Trial (ESCLAIM)
Thoracic endovascular aortic repair plus optimal medical therapy, Optimal medical therapy - Intramural Hematoma
Not applicableUnknownGuangdong Provincial People's Hospital1542021-03-012021-06-03
Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions
aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor, coronary wires. or coronary balloons, drug-coated balloon - Coronary Artery Disease, Coronary Occlusion
Not applicableUnknownBeijing Anzhen Hospital2002021-02-012021-02-09
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Edwards PASCAL System, Optimal Medical Therapy - Tricuspid Regurgitation, Tricuspid Valve Insufficiency
Not applicableRecruitingEdwards Lifesciences12702019-12-112026-09-14
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
Percuteneous Coronary Intervention, Optimal Medical Therapy - Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery
Not applicableRecruitingAarhus University Hospital Skejby15602018-11-062026-01-02
The Role of Willingness of Participation in Cardiology Trials on the Survival of Patients
Optimal medical therapy - Myocardial Infarction, Chronic Heart Failure
UnknownSemmelweis University Heart and Vascular Center4002018-10-012019-02-15
The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel Disease
aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor, coronary wires. stents or coronary balloons - Chronic Total Occlusion of Coronary Artery, Percutaneous Coronary Intervention
UnknownBeijing Anzhen Hospital2402018-04-102020-09-01
Allopurinol and Endothelial Function in Diabetic CAD Patients
Allopurinol - Diabetes Mellitus, Coronary Artery Disease
Not applicableUnknownUniversity Tunis El Manar582017-12-012017-12-28
Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF
MitraClip, Optimal Medical Therapy, CRT-D - Functional Mitral Regurgitation, Heart Failure
Not applicableWithdrawnMontreal Heart Institute2016-12-012020-02-27
Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
Implantable Cardioverter Defibrillator, Optimal Medical Therapy - Angina Pectoris, Variant, Sudden Cardiac Death
Phase 4RecruitingKee-joon Choi1402016-11-292026-06-25
Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study
Left Cardiac Sympathetic Denervation (LCSD), Optimal Medical Therapy - Dilated Cardiomyopathy, Ischemic Cardiomyopathy
Phase 2SuspendedUniversity of Cape Town302016-11-242021-05-06
The British Heart Foundation SENIOR-RITA Trial
Coronary Angiography, Coronary revascularisation, Optimal Medical Therapy - NSTEMI - Non-ST Segment Elevation MI
Not applicableActive not recruitingNewcastle-upon-Tyne Hospitals NHS Trust15182016-11-012024-07-19

Showing 20 of 35. Sign in to see all of them.

Conditions studied

Coronary Artery Disease (8)  ·  Heart Failure (8)  ·  Cardiovascular Diseases (6)  ·  Coronary Disease (4)  ·  Heart Diseases (4)  ·  Myocardial Infarction (4)  ·  Emphysema (3)  ·  Tricuspid Valve Insufficiency (3)  ·  Cardiomyopathies (2)  ·  Heart Valve Diseases (2)  ·  Mitral Valve Insufficiency (2)  ·  Acute Coronary Syndrome (1)  ·  Angina Pectoris (1)  ·  Angina Pectoris, Variant (1)  ·  Angina, Stable (1)

Sponsors

Beijing Anzhen Hospital (2)  ·  Edwards Lifesciences (2)  ·  The First Affiliated Hospital with Nanjing Medical University (2)  ·  Aarhus University Hospital Skejby (1)  ·  Aeris Therapeutics (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Clinical Centre of Serbia (1)  ·  Columbia University (1)  ·  Golden Jubilee National Hospital (1)  ·  Guangdong Provincial People's Hospital (1)  ·  Impulse Dynamics (1)  ·  Johannes Gutenberg University Mainz (1)  ·  Kee-joon Choi (1)  ·  Kerckhoff Klinik (1)  ·  Medical University of Vienna (1)

Countries

United States (9)  ·  Germany (7)  ·  China (6)  ·  France (4)  ·  United Kingdom (4)  ·  Austria (3)  ·  Italy (3)  ·  Canada (2)  ·  Poland (2)  ·  South Korea (2)  ·  Spain (2)  ·  Sweden (2)  ·  Australia (1)  ·  Denmark (1)  ·  Estonia (1)

Top investigators

Leilei Chen (2)  ·  Allen Anderson, MD (1)  ·  Anita Asgar, MD (1)  ·  Anthony Yu, MD, MS (1)  ·  Charles Davidson, MD (1)  ·  Christian Nitsche, MD, PhD (1)  ·  Claudia Walther, MD (1)  ·  Dr Vijay Kunadian, MBBS MD FRCP (1)  ·  Eric J. Rashba, MD (1)  ·  Eric Rose, MD (1)  ·  Evald Christiansen, MD PhD (1)  ·  Felix JF Herth, MD (1)  ·  Gerhard Hindricks, Prof. (1)  ·  Gian Paolo Rossi, MD, FACC (1)

Results publications

PMID 10460813, PMID 10858178, PMID 11253156, PMID 11495621, PMID 12241831, PMID 12622581, PMID 12874185, PMID 14581255, PMID 14683746, PMID 15063816, PMID 15625341, PMID 15660036, PMID 15710757, PMID 15824056, PMID 15864236, PMID 16129869, PMID 16423872, PMID 16757543, PMID 17105848, PMID 17387132, PMID 17502590, PMID 17982163, PMID 18387940, PMID 19188505, PMID 19309733, PMID 19398351, PMID 19463511, PMID 19619694, PMID 20359842, PMID 20661139, PMID 20837929, PMID 20939719, PMID 21062997, PMID 21420046, PMID 22064593, PMID 22922414, PMID 22995877, PMID 22999128, PMID 23644488, PMID 23652265, PMID 23922146, PMID 23968705, PMID 24407049, PMID 25173340, PMID 25385219, PMID 25467378, PMID 25500669, PMID 25728332, PMID 25837041, PMID 26432647

NIH funding

R01HL067683 (1), R01HL070011 (1), R01HL072906 (1), U01HL053986 (1)